(Q26859099)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25018851%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Guilherme Macedo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25018851%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

Rodrigo Liberal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25018851%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Hélder Cardoso

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25018851%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Ana Maria Horta E Vale

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25018851%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

language of work or name

1 reference

27 June 2014

1 reference

World Journal of Hepatology

published in

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25018851%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

volume

6

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25018851%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

issue

6

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25018851%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

page(s)

410-418

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25018851%20AND%20SRC:MED&resulttype=core&format=json

Review article: the management of autoimmune hepatitis beyond consensus guidelines

12 June 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

Update on autoimmune hepatitis

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

Clinical features and management of autoimmune hepatitis

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

Autoimmune hepatitis: Contrasts and comparisons in children and adults - a comprehensive review

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

Autoimmune hepatitis in diverse ethnic populations and geographical regions

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

Autoimmune hepatitis: a comprehensive review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

Drug choices in autoimmune hepatitis: part B--Nonsteroids

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

Autoimmune hepatitis: focusing on treatments other than steroids

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

Advances in the current treatment of autoimmune hepatitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

Autoimmune hepatitis in special patient populations

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

Therapy of autoimmune hepatitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

Therapeutic strategies for autoimmune hepatitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

A Case of Autoimmune Hepatitis Treated with Rituximab

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

Treatment of autoimmune hepatitis: a review of current and evolving therapies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

Diagnosis and management of autoimmune hepatitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

Treatment options for autoimmune hepatitis: a systematic review of randomized controlled trials

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

Difficult treatment decisions in autoimmune hepatitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

Emerging opportunities for site-specific molecular and cellular interventions in autoimmune hepatitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

Efficacy of ursodeoxycholic acid for Japanese patients with autoimmune hepatitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

Current status on B-cell depletion therapy in autoimmune diseases other than rheumatoid arthritis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

A single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

Low-dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

Testicular Ischemia Due to Intravascular Large B-Cell Lymphoma: A Novel Presentation in an Immunosuppressed Individual

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

Mycophenolate mofetil--is it worth the cost? The in-favor opinion

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

Treatment of autoimmune hepatitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

Short-term cyclosporine induces a remission of autoimmune hepatitis in children.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

Oral budesonide for treatment of autoimmune chronic active hepatitis.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

The bactericidal action of benzoic acid and sodium acetate on the gram-negative flora of dialysis fluid

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis

31 May 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I6.410

Simplified criteria for the diagnosis of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I6.410

Treatment response in patients with autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I6.410

Prognosis of histological cirrhosis in type 1 autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I6.410

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I6.410

Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I6.410

Allopurinol safely and effectively optimises thiopurine metabolites in patients with autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I6.410

Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I6.410

Histological changes after the use of mycophenolate mofetil in autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I6.410

Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I6.410

Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I6.410

Mycophenolate mofetil as second line therapy in autoimmune hepatitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I6.410

Mycophenolate mofetil for autoimmune hepatitis: a single practice experience

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I6.410

Mycophenolate mofetil as rescue treatment for autoimmune liver disease in children: a 5-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I6.410

Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naïve patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I6.410

Cyclosporin in the treatment of corticosteroid resistant autoimmune chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I6.410

A case of difficult-to-treat autoimmune hepatitis successfully managed by TNF-alpha blockade

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

Empiric therapy of autoimmune hepatitis with mycophenolate mofetil: comparison with conventional treatment for refractory disease

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

Efficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitis

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

Cyclosporine therapy in patients with steroid resistant autoimmune hepatitis.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081615

Pathogenesis of autoimmune hepatitis

28 November 2018

1 reference

12 December 2020

Thiopurine methyltransferase phenotype and genotype in relation to azathioprine therapy in autoimmune hepatitis

1 reference

12 December 2020

Present status of autoimmune hepatitis in Japan: a nationwide survey

1 reference

12 December 2020

British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis

1 reference

12 December 2020

Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis

1 reference

12 December 2020

Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trial

1 reference

12 December 2020

The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes

1 reference

12 December 2020

Features and consequences of untreated type 1 autoimmune hepatitis

1 reference

12 December 2020

Successful treatment of refractory type 1 autoimmune hepatitis with methotrexate

1 reference

12 December 2020

Extraocular muscle degeneration and regeneration after exposure of rats to incandescent radiant energy

1 reference

12 December 2020

Application of the 2010 American Association for the study of liver diseases criteria of remission to a cohort of Italian patients with autoimmune hepatitis

1 reference

12 December 2020

1 reference

12 December 2020

Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis

1 reference

12 December 2020

Identifiers

DOI

10.4254/WJH.V6.I6.410

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25018851%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25018851%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

PubMed publication ID

25018851

2 references